Nora Bayani - Concepedia

Concepedia

Author

Nora Bayani

Lawrence Berkeley National Laboratory

Also Known As

Bayani, N., Bayani, Nora, Das Debopriya, N. Bayani, Nora Bayani

53

Publications

4.6K

Citations

13

H-Index

21

Concepts

All Affiliations

Lawrence Berkeley National Laboratory University of California, San Francisco Oregon Health & Science University University of California, Berkeley UCSF Helen Diller Family Comprehensive Cancer Center

NB

About

Nora Bayani is an author at Lawrence Berkeley National Laboratory specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	3.8K
2	Cell Biology	5	5	3.8K
3	Health Sciences	2	2	3.2K
4	Pharmacology	1	1	501
5	Cancer Cell Biology	1	1	11

Nora Bayani

×

13

Publications

4.6K

Citations

12

H-Index

	Year	Citations
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Richard M. Neve, Koei Chin, Jane Fridlyand, Cancer Cell Tumor BiologyBreast OncologyEndocrine-related CancerTumor HeterogeneityMedicine	2006	3.2K
Subtype and pathway specific responses to anticancer compounds in breast cancer Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo, Proceedings of the National Academy of Sciences Drug TargetBreast OncologyChemoprevention StrategyTherapeutic CompoundsCancer Biology	2011	501
Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser, Cancer Research	2009	386
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer Zhi Hu, Ge Huang, Anguraj Sadanandam, Breast Cancer Research	2010	137
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer Hayley Donnella, James T. Webber, Rebecca S. Levin, Nature Chemical Biology MedicineReceptor Tyrosine KinasePi3k-pathway Inhibitor EfficacyCancer BiologyBreast Cancer	2018	88
Causal network inference using biochemical kinetics Chris J. Oates, Frank Dondelinger, Nora Bayani, Bioinformatics	2014	59
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease Rebecca Smith, Moqing Liu, Tiera Liby, Scientific Reports	2020	59
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells Wei-Ching Chen, Minh D. To, Peter M.K. Westcott, Nature Communications	2021	47
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer Zhi Hu, Jian‐Hua Mao, Christina Curtis, Breast Cancer Research	2016	38
Integrating biological knowledge into variable selection: an empirical Bayes approach with an application in cancer biology Steven M. Hill, Richard M. Neve, Nora Bayani, BMC Bioinformatics	2012	28

Page 1